U.S. markets close in 6 hours 16 minutes
  • S&P 500

    4,263.19
    -16.96 (-0.40%)
     
  • Dow 30

    33,659.31
    -101.74 (-0.30%)
     
  • Nasdaq

    13,014.49
    -32.70 (-0.25%)
     
  • Russell 2000

    2,016.62
    +41.36 (+2.09%)
     
  • Crude Oil

    87.09
    -5.00 (-5.43%)
     
  • Gold

    1,795.30
    -20.20 (-1.11%)
     
  • Silver

    20.18
    -0.51 (-2.48%)
     
  • EUR/USD

    1.0212
    -0.0045 (-0.44%)
     
  • 10-Yr Bond

    2.7730
    -0.0760 (-2.67%)
     
  • GBP/USD

    1.2097
    -0.0042 (-0.35%)
     
  • USD/JPY

    132.6330
    -0.8470 (-0.63%)
     
  • BTC-USD

    24,088.48
    -385.95 (-1.58%)
     
  • CMC Crypto 200

    571.84
    -18.92 (-3.20%)
     
  • FTSE 100

    7,486.12
    -14.77 (-0.20%)
     
  • Nikkei 225

    28,871.78
    +324.80 (+1.14%)
     

What Type Of Shareholders Own The Most Number of Endo International plc (NASDAQ:ENDP) Shares?

  • Oops!
    Something went wrong.
    Please try again later.
·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Every investor in Endo International plc (NASDAQ:ENDP) should be aware of the most powerful shareholder groups. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. Companies that have been privatized tend to have low insider ownership.

Endo International is not a large company by global standards. It has a market capitalization of US$123m, which means it wouldn't have the attention of many institutional investors. In the chart below, we can see that institutional investors have bought into the company. We can zoom in on the different ownership groups, to learn more about Endo International.

Check out our latest analysis for Endo International

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Endo International?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

As you can see, institutional investors have a fair amount of stake in Endo International. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Endo International's earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth
earnings-and-revenue-growth

Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. It would appear that 14% of Endo International shares are controlled by hedge funds. That's interesting, because hedge funds can be quite active and activist. Many look for medium term catalysts that will drive the share price higher. BlackRock, Inc. is currently the largest shareholder, with 16% of shares outstanding. With 12% and 7.4% of the shares outstanding respectively, The Vanguard Group, Inc. and Paulson & Co. Inc. are the second and third largest shareholders.

We also observed that the top 8 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

Insider Ownership Of Endo International

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

Our information suggests that Endo International plc insiders own under 1% of the company. It seems the board members have no more than US$998k worth of shares in the US$123m company. Many investors in smaller companies prefer to see the board more heavily invested. You can click here to see if those insiders have been buying or selling.

General Public Ownership

The general public, who are usually individual investors, hold a 17% stake in Endo International. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Be aware that Endo International is showing 3 warning signs in our investment analysis , and 1 of those is a bit concerning...

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.